tiprankstipranks
Trending News
More News >
Tyra Bioscience (TYRA)
NASDAQ:TYRA
US Market

Tyra Bioscience (TYRA) Financial Statements

Compare
108 Followers

Tyra Bioscience Financial Overview

Tyra Bioscience's market cap is currently $1.56B. The company's EPS TTM is $-0.5; its P/E ratio is -15.53; Tyra Bioscience is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ -47.00K
Operating Income$ -104.18M$ -79.94M$ -58.93M$ -26.29M$ -9.30M
EBITDA$ -103.66M$ -79.59M$ -58.63M$ -26.15M$ -9.25M
Net Income$ -86.48M$ -69.13M$ -55.33M$ -26.29M$ -9.31M
Balance Sheet
Cash & Short-Term Investments$ 341.44M$ 203.47M$ 251.21M$ 302.18M$ 15.22M
Total Assets$ 363.56M$ 225.86M$ 266.18M$ 306.70M$ 16.01M
Total Debt$ 6.22M$ 6.50M$ 2.62M$ 1.18M$ 142.00K
Net Debt$ -85.74M$ -51.51M$ -248.59M$ -301.00M$ -15.08M
Total Liabilities$ 20.41M$ 21.59M$ 8.35M$ 4.96M$ 29.65M
Stockholders' Equity$ 343.15M$ 204.26M$ 257.83M$ 301.74M$ -13.64M
Cash Flow
Free Cash Flow$ -70.44M$ -50.91M$ -50.84M$ -24.41M$ -8.07M
Operating Cash Flow$ -69.77M$ -50.14M$ -50.28M$ -23.75M$ -7.76M
Investing Cash Flow$ -98.40M$ -144.60M$ -559.00K$ -645.00K$ -312.00K
Financing Cash Flow$ 202.14M$ 1.54M$ 632.00K$ 311.35M$ 23.43M
Currency in USD

Tyra Bioscience Earnings and Revenue History

Tyra Bioscience Debt to Assets

Tyra Bioscience Cash Flow

Tyra Bioscience Forecast EPS vs Actual EPS